Skip to main navigation
Skip to search
Skip to main content
Columbia University Home
Help & FAQ
English
Français
Español
Home
Profiles
Research units
Research output
Equipment
Datasets
Projects & Clinical Trials
Activities
Prizes
Courses
Student theses
Search by expertise, name or affiliation
DAILY VITAMIN D FOR SICKLE-CELL RESPIRATORY COMPLICATIONS: PHASE 2: IND107584 - 11/14/17
Brittenham, Gary M.
(PI)
Lee, Margaret T
(CoPI)
Columbia University
Project
:
Research project
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Colecalciferol
100%
Vitamin D
100%
Sickle Cell
100%
Clinical Trial
35%
Sickle-Cell Disease
28%
Supplementation
14%
Drug Megadose
14%
Respiratory Tract Infection
7%
Biological Marker
7%
Acute Chest Syndrome
7%
25 Hydroxyvitamin D
7%
Immune Function
7%
T Cell
7%
Asthma
7%
Adolescent
7%
Adipose Tissue
7%
Lung Function
7%
Placebo
7%
Pharmacology, Toxicology and Pharmaceutical Science
Vitamin D
100%
Cholecalciferol
100%
Clinical Trial
35%
Sickle Cell Anemia
28%
Respiratory Tract Infection
7%
Inflammation
7%
Asthma
7%
Acute Chest Syndrome
7%
25 Hydroxyvitamin D
7%
Biological Marker
7%
Placebo
7%